Episode 81 – Progress in HIV Cure Research: Can a Single Shot Deliver a Functional Cure? – Dr Steven Deeks (June 30, 2026)
Episode 81 – Progress in HIV Cure Research: Can a Single Shot Deliver a Functional Cure? – Dr Steven Deeks (June 30, 2026)
Episode 80 – TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker (June 16, 2026)
Episode 79 – Special Episode – Latest Update on Emerging Infections and Health Threats (June 15, 2026)
Episode 79 – Special Episode – Latest Update on Emerging Infections and Health Threats (June 15, 2026)
Episode 79 – Special Episode – Latest Update on Emerging Infections and Health Threats (June 15, 2026)
(June 9, 2026) IAS-USA Dialogue Series: Emerging Infections and Health Threats
Moderators: Carlos del Rio, MD (Emory University);
Discussants: Yvonne Maldonado, MD (Stanford University); Peter Chin-Hong, MD (University of California San Francisco)
Episode 78 – From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi (June 2, 2026)
Episode 78 – From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi (June 2, 2026)
Episode 77 – Management of Hepatitis B Infection and Vaccination – Dr Debika Bhattacharya (May 19, 2026)
Episode 77 – Management of Hepatitis B Infection and Vaccination – Dr Debika Bhattacharya (May 19, 2026)
IAS–USA Course Features Doravirine/Islatravir Following FDA Approval
The US Food and Drug Administration has approved doravirine 100 mg/islatravir 0.25 mg, a once-daily, single-tablet, 2-drug regimen for adults with virologically suppressed HIV-1. The regimen is indicated for individuals who have maintained viral suppression for at least 3 months, with no history of treatment failure or known resistance to doravirine. In phase III trials, the combination […]
Shobha Swaminathan, MD, Named Cochair of 2026 RWHAP CLINICAL CONFERENCE
We are pleased to announce that Shobha Swaminathan, MD, of Rutgers New Jersey Medical School, will serve as the third cochair for the 2026 Ryan White HIV/AIDS Program CLINICAL CONFERENCE, alongside Britt Gayle, MD, MPH, of the HIV/AIDS Bureau of the Health Resources and Services Administration in Rockville, Maryland, and Michael S. Saag, MD, of […]